AUS
NZ
UK
CA
USA
IND
Healthcare
Northwest Urgent Care (NYSE:CYH) Expands with Acquisition of 10 Arizona Urgent Care Centers
September 16, 2024 10:05 PM PDT| By Team Kalkine MediaNorthwest Urgent Care, LLC, a Tucson-based subsidiary of Community Health Systems, Inc. (NYSE:CYH), has announced a significant expansion through the acquisition of 10 urgent care centers in Arizona from Carbon Health. This strategic move will signif...
Dermata Therapeutics (NASDAQ: DRMA, DRMAW) Secures $3.5 Million in Private Placement Offering
September 16, 2024 09:11 PM PDT| By Team Kalkine MediaDermata Therapeutics, Inc. (NASDAQ: DRMA, DRMAW), a late-stage biotechnology company specializing in medical and aesthetic skin treatments, has announced a significant financing deal. The company has entered into definitive agreements to issue and se...
Foghorn Therapeutics Sees Increase Amid High Trading Volume
September 16, 2024 03:47 AM PDT| By Team Kalkine MediaIn the,Healthcare sector,, Foghorn Therapeutics Inc. experienced a 9.5% increase in its share price, closing at $9.72 during the last trading session. This rise was accompanied by a significant increase in trading volume compared to typical sessions....
Recent Diagnostics Innovations Drive Company’s Success
September 16, 2024 03:01 AM PDT| By Team Kalkine MediaIn the,healthcare sector,, Abbott Laboratories has recently experienced noteworthy developments that underscore its continued strength in a key business segment. Abbott’s recent advancements in this area have highlighted the company's ongoing commitm...
FDA Approves Roche's OCREVUS ZUNOVO for Multiple Sclerosis Treatment
September 16, 2024 01:41 AM PDT| By Team Kalkine MediaIn the,healthcare sector,, Swiss pharmaceutical company Roche has secured approval from the U.S. Food and Drug Administration (FDA) for its new treatment, OCREVUS ZUNOVO (ocrelizumab & hyaluronidase-ocsq). This approval allows the use of OCREVUS ZUNO...
Factors Driving UnitedHealth’s Recent Stock Performance
September 13, 2024 11:10 AM PDT| By Team Kalkine MediaUnitedHealth Group Incorporated has recently experienced an upward movement in its stock price, driven by several key factors within the,healthcare sector,. The company's performance reflects its ability to navigate a complex and competitive environm...
GSK's Blood Cancer Drug Receives Breakthrough Therapy Designation
September 13, 2024 03:13 AM PDT| By Team Kalkine MediaA major player of,Healthcare sector,, GSK PLC (,NYSE:GSK,) has received Breakthrough Therapy Designation (BTD) in China for its blood cancer medication, Blenrep (belantamab mafodotin). The designation, granted by the National Medical Products Adminis...
Moderna (NASDAQ:MRNA) Plans Significant Cuts to R&D Spending, Eyes Break-Even by 2028
September 12, 2024 11:08 PM PDT| By Team Kalkine MediaIn a strategic move aimed at optimizing financial performance, Moderna (NASDAQ:MRNA) has announced plans to cut its research and development (R&D) spending by 20% for the years 2025 to 2028. This reduction will bring the total R&D expenditure down to...
Moderna Restructures R&D Strategy, Anticipates $1.1B Savings
September 12, 2024 04:59 PM PDT| By Team Kalkine MediaHeadlines,- Moderna plans to streamline its research and development efforts, focusing on obtaining FDA approval for 10 key products.,- The company expects to reduce R&D expenses by $1.1 billion by 2027, with significant cost-cutting measures startin...
GSK Advances mRNA Flu Vaccine to Phase III Trials After Positive Results
September 12, 2024 03:56 AM PDT| By Team Kalkine MediaGSK PLC, a major player in the,Healthcare sector,, has reported positive initial results from its seasonal flu vaccine using mRNA technology. The FTSE 100 company announced that the phase II trial of its mRNA-based influenza vaccine has shown promisi...
Futura Medical's Revenue Forecasts Upgraded Significantly
September 12, 2024 02:15 AM PDT| By Team Kalkine MediaFutura Medical PLC, operating in the,healthcare sector,, has reported a substantial upgrade in its revenue forecasts following its latest interim results, which surpassed expectations. The company's recent performance has positioned it to post its fi...
Revolutionizing Wound Care: SOLV’s V.A.C. Peel and Place Dressing
September 11, 2024 06:24 PM PDT| By Team Kalkine MediaInnovative Solution for Wound Therapy,SOLV's latest launch, the V.A.C. Peel and Place Dressing, addresses longstanding challenges in negative pressure wound therapy. This cutting-edge product promises to make wound care more accessible and comfortabl...
LivaNova Experiences Significant Increase in Three-Year Losses
September 11, 2024 12:26 PM PDT| By Team Kalkine MediaLivaNova has reported a notable increase in its financial losses over the past three years, with losses growing to 44% compared to earlier periods. This trend highlights ongoing challenges faced by the company within the,healthcare sector,.,Financial...
ANGLE Technology Sets the Standard in Cancer Diagnostics, Says Leading Financial Institution
September 11, 2024 04:05 AM PDT| By Team Kalkine MediaANGLE PLC,(OTC:ANPCF),is at the forefront of cancer diagnostics with its cutting-edge circulating tumour cell (CTC) technology. Recognized as the 'gold standard' in its field by a prominent German financial institution, the company’s Parsortix system...
Berenberg Signals GSK's Challenges Are Clearing
September 11, 2024 03:53 AM PDT| By Team Kalkine MediaGSK PLC,(OTC:GLAXF),has been noted by broker Berenberg, which highlights a potential easing of challenges that have impacted the pharmaceutical group throughout the summer. A major factor has been the Zantac litigation in Delaware, alongside concerns...
Futura Medical Hits Profitability Early with Impressive Interim Results
September 11, 2024 03:37 AM PDT| By Team Kalkine MediaA major player of,Healthcare sector,, Futura Medical PLC has announced notable progress in its latest interim results, showcasing a significant milestone for the company. The results highlight the company’s successful transition to profitability earl...
Liraglutide Shows Safety and Efficacy for Childhood Obesity in Recent Study
September 11, 2024 03:07 AM PDT| By Team Kalkine MediaThe,healthcare sector,may see a significant development as new clinical findings indicate that liraglutide, a drug already approved for obesity treatment in adults and adolescents, is also safe and effective for children as young as six years old whe...
GSK Halts Further Trials for Herpes Vaccine Following Disappointing Phase II Results
September 11, 2024 02:55 AM PDT| By Team Kalkine MediaShares of GSK PLC experienced a decline of over 1% after the,Healthcare secto,r company announced its decision to discontinue further trials for its experimental herpes vaccine, GSK3943104. The decision came in response to unsatisfactory results from...
iRhythm's Zio Monitor Enhances Performance with Latest Study Findings
September 10, 2024 12:02 PM PDT| By Team Kalkine MediaHeadlines,- iRhythm Technologies,(NASDAQ:IRTC),has unveiled promising results from the latest research on its Zio LTCM monitor, highlighting significant improvements in device performance.,- The Zio LTCM monitor, featuring a new design with a waterpr...
Intrinsic Value Examination of 111 Inc. Reveals Current Market Insights
September 10, 2024 09:43 AM PDT| By Team Kalkine MediaIn the,Healthcare sector,, 111 Inc. has recently been evaluated to understand its intrinsic value and current market position. This sector, known for its dynamic nature and shifting consumer preferences, is vital in assessing how well companies like...
